X

There has never been a better time to consider China as part of your development strategy!

In another encouraging step towards making China a leading destination for clinical drug trials, some…

George Clinical

George Clinical Promotes Matthew Reabold, Sr., to Head of Business Development, USA

George Clinical, a leading full-service CRO in the US and Asia-Pacific region, is pleased to announce that Matthew…

George Clinical

George Clinical leads China Component and Recruitment in World-First Large CPAP Device Trial

The Study Although Obstructive sleep apnea (OSA) is a very common condition that is associated…

George Clinical

Significant changes ahead for drug development in China?

Significant changes are ahead for clinical research in China. The Public Consultation Notice for Policies…

Philip Gregory

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

Sydney, Australia (May 2, 2017) – George Clinical, a leading full-service CRO in the Asia-Pacific…

George Clinical

Hong Kong Wholesale Dealer Licence

George Clinical is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence…

George Clinical

Taiwan: The Clinical Trials Gateway to China?

Taiwan sits, along with its smaller counterparts, Singapore and Hong Kong, as one of the…

George Clinical

South Korea: A Top Clinical Trial Destination

Clinical trial sponsors and CROs don’t need to imagine South Korea as a country of…

George Clinical

International Women’s Day

As the world stops to celebrate and reflect on International Women’s Day on the 8th…

George Clinical

George Clinical Scientific Leaders boost recruitment for Phase 1 Patient Study

Utilizing key therapeutic knowledge leader networks as championed by George Clinical has again shown its…

George Clinical